<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The impact of human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> on the outcome of patients with acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>)-related <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with life-threatening complications requiring intensive care unit (ICU) admission is not well known </plain></SENT>
<SENT sid="1" pm="."><plain>The objective of this study was to compare the outcome of patients with <z:hpo ids='HP_0002665'>lymphoma</z:hpo> transferred to the ICU according to <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> status </plain></SENT>
<SENT sid="2" pm="."><plain>The clinical characteristics, reason for ICU admission, and outcome of 48 consecutive <z:e sem="disease" ids="C0010340" disease_type="Disease or Syndrome" abbrv="">critically ill</z:e> patients with <z:hpo ids='HP_0002665'>lymphoma</z:hpo> admitted to the ICU from January 2000 to March 2010 was retrospectively analyzed, focusing on their HIV serology status </plain></SENT>
<SENT sid="3" pm="."><plain>Thirty-six patients were HIV-negative and 12 patients HIV-positive </plain></SENT>
<SENT sid="4" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was more frequent in HIV-infected patients, whereas diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was more frequent in HIV-negative patients </plain></SENT>
<SENT sid="5" pm="."><plain>The main <z:hpo ids='HP_0011009'>acute</z:hpo> life-threatening diseases precipitating ICU transfer were similar in both groups </plain></SENT>
<SENT sid="6" pm="."><plain>Severe <z:hpo ids='HP_0001875'>neutropenia</z:hpo> was more frequent in HIV-positive than in HIV-negative patients </plain></SENT>
<SENT sid="7" pm="."><plain>With a median follow-up of 53 months after ICU admission, the overall survival probabilities were 15% (95% confidence interval [CI]: 3-27%) and 17% (95% CI: 0-38%) for HIV-negative and HIV-positive patients, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>The 2-year survival probabilities were 34% (95% CI: 10-58%) and 40% (95% CI: 0-43%) for HIV-negative and HIV-positive patients discharged from the ICU, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>In this study, <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> did not have a negative impact on the outcome of patients with <z:hpo ids='HP_0002665'>lymphoma</z:hpo> admitted to the ICU </plain></SENT>
</text></document>